Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kristina V. Kitaeva"'
Autor:
Ivan Y. Filin, Yuri P. Mayasin, Chulpan B. Kharisova, Anna V. Gorodilova, Kristina V. Kitaeva, Daria S. Chulpanova, Valeriya V. Solovyeva, Albert A. Rizvanov
Publikováno v:
International Journal of Molecular Sciences. 24:2413
Melanoma is one of the most aggressive and therapy-resistant types of cancer, the incidence rate of which grows every year. However, conventional methods of chemo- and radiotherapy do not allow for completely removing neoplasm, resulting in local, re
Autor:
Daria S. Chulpanova, Valeriya V. Solovyeva, Albert A. Rizvanov, Alisa A. Shaimardanova, Kristina V. Kitaeva
Publikováno v:
Genes & Cells. 15:17-22
Tay-Sachs disease (OMIM 272800) belongs to the group of autosomal-recessive disorders, caused by p-hexosaminidase A (HexA) enzyme deficiency, resulting in GM2-ganglioside accumulation in nervous and other tissues of the body. Enzyme deficiency is cau
Autor:
Ekaterina V. Martynova, Anton F. Shamsutdinov, Richard A. Urbanowicz, Svetlana F. Khaiboullina, Ekaterina E. Garanina, T A Savitskaya, Guzel Isaeva, Yuriy N. Davidyuk, Sergey P. Morzunov, Cyprian Katongo, Emmanuel Kabwe, Albert A. Rizvanov, Kristina V. Kitaeva, Moffat Malisheni
Publikováno v:
Pathogens
Pathogens, Vol 9, Iss 775, p 775 (2020)
Pathogens, Vol 9, Iss 775, p 775 (2020)
Orthohantaviruses give rise to the emerging infections such as of hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) in Eurasia and the Americas, respectively. In this review we will provide a comprehensive analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b4a4ab40969a1dab7b9a7a5de9df91c
Autor:
Catrin S. Rutland, Valeriya V. Solovyeva, Daria S. Chulpanova, Kristina V. Kitaeva, Albert A. Rizvanov
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 4118, p 4118 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 4118, p 4118 (2020)
Recent advances in the development of new methods of cancer immunotherapy require the production of complex cancer animal models that reliably reflect the complexity of the tumor and its microenvironment. Mice are good animals to create tumor models